Derivatisation-free FIA-MS/MS assay for rapid simultaneous screening of atypical myopathy biomarkers and acylcarnitine profiles from dried blood spots
Analytical and Bioanalytical Chemistry · 2026-07 · 418 (14) · 4637-4649
DOI: 10.1007/s00216-026-06566-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical and Bioanalytical Chemistry, online erschienen am 27.05.2026. Verfasst von Martina Kadláčková und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory for Inherited Metabolic Disorders, Department of Medical Genetics, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotín…. Hauptthemen laut MEDLINE: Carnitine, Tandem Mass Spectrometry, Muscular Diseases, Hypoglycins. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerstvo Zdravotnictví Ceské Republiky, Národní Agentura pro Zemědělský Výzkum, Palacky University Olomouc.
Abstract (Originalsprache)
Atypical myopathy (AM) is a frequently fatal, toxin-induced disease in horses, characterised by acute progression and mortality rates exceeding 70% within 72 h. The disease is caused by ingestion of seedlings or seeds of certain maple species that contain the toxins hypoglycin A (HGA) and methylenecyclopropylglycine (MCPrG). Early diagnosis depends on reliable detection of these compounds and their metabolites. However, most available LC-MS/MS assays are limited by derivatisation requirements and dependence on serum and urine matrices. Here, a rapid derivatisation-free flow injection analysis (FIA)-tandem mass spectrometry (MS/MS) method was developed for the simultaneous quantification of nine analytes: HGA, methylenecyclopropylacetyl-carnitine (MCPA-carnitine), and seven diagnostically relevant acylcarnitines, from dried blood spots (DBS). The procedure requires only 50 µL of whole blood, minimal sample preparation, and enables results within one minute. The assay provides low limits of quantification (0.01–0.1 μmol/L) with excellent linearity (R2 > 0.994), exhibiting analytical performance suitable for rapid screening of AM biomarkers. Moreover, analytes showed adequate stability in DBS during short-term storage at ambient temperature and prolonged storage at −20 °C. Clinical performance of the workflow was evaluated using 17 DBS samples from horses with AM and 15 control DBS samples. AM cases were defined based on the high specificity of HGA and MCPA-carnitine, with accompanying acylcarnitine profiles reflecting disease-associated metabolic disruption. Over 2 years, more than 250 DBS samples from horses suspected of AM were routinely analysed. Overall, the results establish a robust, high-throughput FIA-MS/MS platform integrating DBS sampling with non-derivatised analysis, offering a practical screening tool for remote sample collection, efficient transport, and multi-analyte diagnosis of AM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory for Inherited Metabolic Disorders, Department of Medical Genetics, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 779 00, Olomouc, Czech Republic.
- Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Zdravotníků 248/7, 779 00, Olomouc, Czech Republic.
- Equine Clinic, Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Palackého třída 1946/1, 612 00, Brno-Královo Pole, Czech Republic.
- Laboratory for Inherited Metabolic Disorders, Department of Medical Genetics, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 3, 779 00, Olomouc, Czech Republic. radana.brumarova@upol.cz.
- Laboratory for Inherited Metabolic Disorders, Department of Clinical Biochemistry, University Hospital Olomouc, Zdravotníků 248/7, 779 00, Olomouc, Czech Republic. radana.brumarova@upol.cz.
Förderung
- Ministerstvo Zdravotnictví Ceské Republiky
- Národní Agentura pro Zemědělský Výzkum
- Palacky University Olomouc
Zitieren
APA
Kadláčková, M., Dobešová, D., Ivanovová, E., Masař, R., Jahn, P., Šamonilová, E., Friedecký, D., & Brumarová, R. (2026). Derivatisation-free FIA-MS/MS assay for rapid simultaneous screening of atypical myopathy biomarkers and acylcarnitine profiles from dried blood spots. Analytical and Bioanalytical Chemistry, 418(14), 4637-4649. https://doi.org/10.1007/s00216-026-06566-3
Vancouver
Kadláčková M, Dobešová D, Ivanovová E, Masař R, Jahn P, Šamonilová E, et al. Derivatisation-free FIA-MS/MS assay for rapid simultaneous screening of atypical myopathy biomarkers and acylcarnitine profiles from dried blood spots. Analytical and Bioanalytical Chemistry. 2026;418(14):4637-4649. doi:10.1007/s00216-026-06566-3
BibTeX
@article{Kadlkov2026,
author = {Kadláčková, Martina and Dobešová, Dana and Ivanovová, Eliška and Masař, Richard and Jahn, Petr and Šamonilová, Eva and Friedecký, David and Brumarová, Radana},
title = {Derivatisation-free FIA-MS/MS assay for rapid simultaneous screening of atypical myopathy biomarkers and acylcarnitine profiles from dried blood spots},
journal = {Analytical and Bioanalytical Chemistry},
year = {2026},
volume = {418},
number = {14},
pages = {4637--4649},
doi = {10.1007/s00216-026-06566-3}
}
EUVIMED